Your browser is no longer supported. Please, upgrade your browser.
Settings
TMDX TransMedics Group, Inc. daily Stock Chart
TMDX [NASD]
TransMedics Group, Inc.
Index- P/E- EPS (ttm)-1.68 Insider Own1.10% Shs Outstand21.22M Perf Week-3.33%
Market Cap434.98M Forward P/E- EPS next Y-0.94 Insider Trans-8.68% Shs Float15.06M Perf Month15.03%
Income-35.50M PEG- EPS next Q-0.45 Inst Own56.20% Short Float7.20% Perf Quarter11.89%
Sales26.50M P/S16.41 EPS this Y-101.20% Inst Trans0.81% Short Ratio5.81 Perf Half Y-6.24%
Book/sh2.20 P/B7.65 EPS next Y43.40% ROA-32.60% Target Price19.75 Perf Year-33.96%
Cash/sh2.81 P/C6.00 EPS next 5Y- ROE-60.20% 52W Range10.10 - 27.42 Perf YTD-11.42%
Dividend- P/FCF- EPS past 5Y- ROI-33.40% 52W High-38.58% Beta-
Dividend %- Quick Ratio5.30 Sales past 5Y- Gross Margin61.00% 52W Low66.73% ATR0.94
Employees109 Current Ratio6.10 Sales Q/Q59.60% Oper. Margin- RSI (14)51.45 Volatility4.22% 5.87%
OptionableNo Debt/Eq0.73 EPS Q/Q-22.40% Profit Margin- Rel Volume0.52 Prev Close17.51
ShortableYes LT Debt/Eq0.73 EarningsMay 06 AMC Payout- Avg Volume186.73K Price16.84
Recom1.80 SMA200.59% SMA505.09% SMA200-1.54% Volume96,215 Change-3.83%
Apr-07-20Initiated Oppenheimer Outperform $25
May-28-19Initiated Morgan Stanley Equal-Weight
May-28-19Initiated JP Morgan Overweight
May-28-19Initiated Cowen Outperform
May-28-19Initiated Canaccord Genuity Buy
Jun-04-20 10:11PM  
May-27-20 11:14AM  
May-26-20 06:50PM  
07:14AM  
07:09AM  
May-07-20 11:30AM  
May-06-20 04:05PM  
Apr-29-20 12:34PM  
Apr-23-20 04:05PM  
Apr-13-20 04:05PM  
Mar-17-20 09:20AM  
07:00AM  
Mar-02-20 04:05PM  
Feb-20-20 04:05PM  
Feb-19-20 04:05PM  
Jan-17-20 09:39AM  
Dec-22-19 05:10PM  
Dec-19-19 08:00AM  
Dec-09-19 08:58AM  
Dec-04-19 08:00AM  
Nov-06-19 07:30AM  
Nov-01-19 02:17PM  
Oct-23-19 04:05PM  
Oct-16-19 04:05PM  
Sep-17-19 01:45PM  
Aug-26-19 04:05PM  
Aug-21-19 05:35PM  
Aug-07-19 04:05PM  
Aug-02-19 08:21AM  
Jul-30-19 08:30AM  
Jul-25-19 04:05PM  
Jul-17-19 04:05PM  
Jun-30-19 08:11AM  
Jun-11-19 04:05PM  
02:30PM  
Jun-03-19 08:00AM  
May-30-19 04:05PM  
May-06-19 04:15PM  
May-01-19 01:25PM  
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion apparatus, optimization, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carey John FVP of OperationsJul 01Option Exercise1.402,0002,7935,200Jul 02 07:42 PM
Carey John FVP of OperationsJul 01Sale17.092,00034,1743,200Jul 02 07:42 PM
Carey John FVP of OperationsJun 01Option Exercise0.392,0007805,200Jun 02 06:10 PM
Carey John FVP of OperationsJun 01Sale13.212,00026,4203,200Jun 02 06:10 PM
Carey John FVP of OperationsMay 01Option Exercise0.392,0007805,200May 04 06:04 PM
Carey John FVP of OperationsMay 01Sale17.052,00034,1053,200May 04 06:04 PM
Gordon StephenChief Financial OfficerApr 27Sale18.009,900178,20018,571Apr 29 04:22 PM
Gordon StephenChief Financial OfficerApr 22Sale18.001001,80028,471Apr 24 05:54 PM
Carey John FVP of OperationsApr 07Option Exercise0.392,0007805,200Apr 09 04:33 PM
Carey John FVP of OperationsApr 07Sale13.102,00026,2003,200Apr 09 04:33 PM
Hassanein Waleed HPresident & CEOMar 27Option Exercise0.39100,00039,000215,429Mar 30 04:57 PM
Carey John FVP of OperationsMar 02Option Exercise0.392,0007805,200Mar 04 04:30 PM
Carey John FVP of OperationsMar 02Sale15.172,00030,3453,200Mar 04 04:30 PM
Carey John FVP of OperationsFeb 03Option Exercise0.392,0007803,200Feb 05 04:43 PM
Carey John FVP of OperationsFeb 03Sale17.712,00035,4201,200Feb 05 04:43 PM
Khayal Tamer IChief Commercial OfficerJan 21Option Exercise0.395,0001,95051,076Jan 22 04:20 PM
Khayal Tamer IChief Commercial OfficerJan 21Sale20.025,000100,10046,076Jan 22 04:20 PM
Carey John FVP of OperationsJan 17Option Exercise0.282,0005603,200Jan 22 04:19 PM
Carey John FVP of OperationsJan 02Option Exercise0.392,0007803,200Jan 06 04:55 PM
Carey John FVP of OperationsJan 02Sale18.952,00037,9001,200Jan 06 04:55 PM
UNITED THERAPEUTICS Corp10% OwnerDec 09Sale18.75500,0009,375,0002,053,240Dec 10 04:31 PM
Carey John FVP of OperationsNov 15Option Exercise0.281,2003361,200Nov 18 04:39 PM
Sullivan John FVP of Quality & EngineeringNov 15Option Exercise0.281,40039210,828Nov 18 04:38 PM
Weill DavidDirectorNov 11Buy17.0010,000170,00010,000Nov 13 05:05 PM